Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo ...
Reporting 2024 annual financial earnings per share (EPS) of $10.94 and adjusted earnings per share of $11.80, Jason Liberty, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback